The Potential and Limitations of Precision Oncology: Lessons Learned from Whole-Exome Sequencing in an Exceptional Response to Everolimus in Advanced Renal Cell Carcinoma
Amanda Pilling(Henry Ford Health System), Clara Hwang(Henry Ford Health System), Christopher Eing Wee(Mayo Clinic in Arizona), Eliezer Bar-Meir(Wayne State University), Gregory Dyson(The Barbara Ann Karmanos Cancer Institute), Nilesh Gupta(Henry Ford Health System), Ok Kyung Hwang(Henry Ford Health System), Dhananjay Chitale(Henry Ford Hospital)
Cited by 2
Related Papers
Rb Loss Is Characteristic of Prostatic Small Cell Neuroendocrine Carcinoma
|Clinical Cancer Research|2013|358
Succinate dehydrogenase-deficient renal cell carcinoma: detailed characterization of 11 tumors defining a unique subtype of renal cell carcinoma
|Modern Pathology|2014|227
ERG gene rearrangements are common in prostatic small cell carcinomas
|Modern Pathology|2011|219